Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

NCT00872872 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

NVP Plasma Level
NVP Related Mutation
3TC Related Mutation

Interventions

DRUG: AZT/3TC 2 weeks after delivery

Sponsor

Thai Red Cross AIDS Research Centre

Collaborators

[object Object]
[object Object]